| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.2M | -34.2% |
| R&D Expense | $1.4M | -5.3% |
| SG&A Expense | $9.9M | -0.3% |
| Operating Income | -$10.6M | -18.1% |
| Pre-tax Income | -$14.9M | -64.7% |
| Income Tax | $44K | +278.0% |
| Net Income | -$14.9M | -64.9% |
| EPS (Basic) | -$8.66 | -1054.7% |
| EPS (Diluted) | -$8.66 | -1054.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | +483.5% |
| Accounts Receivable | $542K | -52.4% |
| Inventory | $54K | +94.0% |
| Current Assets | $7.6M | +180.7% |
| Total Assets | $11.0M | +68.3% |
| Current Liabilities | $2.9M | -6.4% |
| Total Liabilities | $3.7M | -5.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.3M | -28.4% |
| Capital Expenditures | $61K | -23.4% |
| Investing Cash Flow | -$61K | +23.4% |
| Financing Cash Flow | $14.7M | +161.8% |
| Free Cash Flow | -$9.4M | -27.9% |
| $7.3M |
| +179.7% |